A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis

A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Détails bibliographiques
Auteur principal:	Islam, Nahidul
Autres auteurs:	Talukder, Mesbah
Format:	Thèse
Langue:	English
Publié:	Brac University 2023
Sujets:	Psoriasis Biologics FAERS Interleukin inhibitors Alopecia Pharmacovigilance
Accès en ligne:	http://hdl.handle.net/10361/22025

Documents similaires

TNF-α inhibitor-induced alopecia in psoriatic disease patients: a pharmacovigilance study
par: Afroza, Halima
Publié: (2024)

Biologics and Biosimilars as Treatment Options for Psoriasis
par: Moya, Amena Khatun
Publié: (2023)

Association of GLP-1 receptor agonists and risk of pancreatitis: a pharmacovigilance study based on FAERS database
par: Bishakha, Adwiza Chakraborty
Publié: (2024)

Safety and efficacy of dutasteride for male Androgenetic Alopecia
par: Islam, S.M. Zahidul
Publié: (2024)

Relationship between SGLT2 inhibitor use and risk of lower limb amputations: a pharmacovigilance study
par: Khandker, Tahia Anjum
Publié: (2024)

Investigation of adverse effects of oral voriconazole in the treatment of fungal infection using The FDA Adverse Event Reporting System (FAERS)
par: Onanna, Kazi
Publié: (2024)

A review on interrelation among post-authorisation study, regulatory action and pharmacogenetics in pharmacovigilance
par: Nusrat, Tanzina
Publié: (2019)

Antihypertensive drugs and risk of cancer: A pharmacovigilance study
par: Rahman, Ahadina
Publié: (2018)

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
par: Meem, Manila
Publié: (2023)

A review on potential of PARP inhibitors in the treatment of prostate cancer
par: Islam, Saidul
Publié: (2022)

A survey on the knowledge and attitude on pharmacovigilance among the pharmacy students of different universities of Dhaka, Bangladesh
par: Albee, Md. Hamza
Publié: (2017)

Identification of FAP inhibitors using in silico simulation study
par: Deeba, Maliha Tasnim
Publié: (2018)

A review on newly approved PARP inhibitors: Talazoparib and Olaparib
par: Karim, Azrin
Publié: (2024)

Efficacy and safety of monotherapy and combination therapy of oral minoxidil for androgenetic alopecia: a structured review
par: Jahan, Safrin
Publié: (2023)

Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
par: Tabassum, Nadira
Publié: (2024)

Pharmacokinetics, safety, efficacy and immunogenicity of Adalimumab biosimilar ABP-501in rheumatoid arthritis and plaque psoriasis
par: Akter, Anika
Publié: (2022)

A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine
par: Shehab, Habibul Mohsin
Publié: (2024)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
par: Haque, Mushfiqul
Publié: (2019)

A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
par: Bakar, Osama Bin Abu
Publié: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
par: Flora, Sanzida Alam
Publié: (2024)

A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
par: Khan, Muidul Hasan
Publié: (2024)

Biomarkers in the diagnosis and treatment of Covid-19
par: Kabir, Syeda Shuvessa
Publié: (2023)

A review on the role of Epigenetics in Psychiatry: Etiology, contemporary medicine and future perspectives
par: Oshin, Sadia Afrin
Publié: (2021)

Effect Of sodium glucose co-transporter 2 inhibitors on weight reduction in overweight and obese population: A review
par: Mahin, Md. Tamjidur Rahman
Publié: (2024)

Female Alopecia
par: TrÃ¼eb
Publié: (2013)

RIPK pathway, as a potential target, for cancer treatment - a review
par: Jahan, Nusrat
Publié: (2024)

Study on anticancer drugs approved by the FDA from 2014 to 2023
par: Rattry, Faria Rahman
Publié: (2024)

Recent advancement of biologics in Asthma
par: Evan, Al- Shahriar
Publié: (2022)

A review on cyclin-dependent kinase 7 (CDK7) Inhibitors as anticancer agents
par: Sorno, Rubina Haque
Publié: (2024)

Cross-sectional survey to assess the knowledge, attitude and practice regarding adverse drug reactions of students of a private university
par: Islam, Tarikul
Publié: (2021)

A study on drug product approval by the FDA from 1930 to 2019
par: Jony, Md. Nazmul Islam
Publié: (2023)

Hepatotoxicity and acute kidney injury associations with itraconazole, voriconazole and posaconazole in the treatment of Onychomycosis: pharmacovigilance study of FDA adverse event reporting system data (FAERS)
par: Hossain, Ragib
Publié: (2024)

Recent advances in Cancer treatment targeting autophagy and future aspects
par: Emon, Kamrul Hasan
Publié: (2022)

FDA Consumer

FDA Consumer

FDA Consumer

FDA Consumer

Detection of skin diseases using deep learning
par: Shodoy, Masuk Ur Rahman
Publié: (2024)

Assessment of knowledge and attitude of adverse Ddug reactions among healthcare professionals in Bangladesh
par: Paul, Sanjoy Kumer
Publié: (2021)

Pharmacoepidemiology and Pharmacovigilance